MENLO PARK, Calif.–(BUSINESS WIRE)–Sight Sciences, Inc., a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease, today announced that the company’s management i…
Author: Business Wire
Ocular Therapeutix™ to Present at the Piper Jaffray 31st Annual Healthcare Conference
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
IVERIC bio to Present at Evercore ISI 2nd Annual HealthCONx Conference
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced that Glenn Sblendorio, CEO and President, will present a Company overview at the Evercore ISI 2nd Annual HealthCONx Conference.
Riassunto: GN CORPORATION: restituita la vista con un trapianto di cellule corneali grazie a una tecnica a nano-strati; brevetto rilasciato a una società giapponese in India
TOKYO–(BUSINESS WIRE)–Un innovativo metodo di trapianto cellulare per il trattamento delle patologie dell’endotelio corneale come la cheratopatia bollosa, usando uno strato di gel nanocomposito sviluppato da scienziati giapponesi, ha ottenuto il brev…
GN CORPORATION: Wiederherstellung der Sehkraft durch Transplantation von Hornhautzellen mithilfe einer Nanoblatt-Technik; japanische Firma erhält Patent in Indien
TOKIO (Japan)–(BUSINESS WIRE)–Eine neuartige Methode zur Zelltransplantation ermöglicht die Behandlung von Erkrankungen des Hornhautendothels, zum Beispiel der bullösen Keratopathie, mit einem von japanischen Wissenschaftlern entwickelten Nanoverbund…
Global Contact Lenses Market Review and Outlook, 2016-2019 & 2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Contact Lenses Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2027” report has been added to ResearchAndMarkets.com’s offering. The contact lenses market report provides analysis for the …
Aerie Pharmaceuticals to Present at the Piper Jaffray 31st Annual Healthcare Conference
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
GN CORPORATION: Vision Restored with Corneal Cell Transplant Using a Nano Sheet Technique; Japanese Firm Granted Patent in India
TOKYO–(BUSINESS WIRE)–A novel cell transplantation method to treat corneal endothelial diseases such as bullous keratopathy using a nano-composite gel sheet developed by Japanese scientists was granted Indian patent to GN Corporation (GNC), Japan. Th…
Just in Time for Black Friday: Stanton Optical, a Leading Eye Care Provider, Debuts Retail Store in Wichita
WICHITA, Kan.–(BUSINESS WIRE)– #BlackFriday–Stanton Optical, a retail brand of Now Optics, leading eye care provider, opened its first store in Wichita, Kansas at 438 S. Rock Rd.
Just in Time for Black Friday: Stanton Optical, a Leading Eye Care Provider, Debuts Retail Store in Springfield
SPRINGFIELD, Mo.–(BUSINESS WIRE)– #BlackFriday–Stanton Optical, a retail brand of Now Optics, a leading eye care provider, opened its first store in Springfield, Missouri.
IVERIC bio Appoints Guangping Gao, PhD, Internationally Recognized Gene Therapy Pioneer as Chief Strategist, Gene Therapy
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced today the appointment of Guangping Gao, PhD, as Chief Strategist, Gene Therapy.
Global Ophthalmology Therapeutics Market 2019-2023 | Evolving Opportunities with ALLERGAN and Novartis AG | Technavio
LONDON–(BUSINESS WIRE)– #HealthcareDevices–Global ophthalmology therapeutics market is poised to grow by USD 9.6 billion during 2019-2023 at a CAGR of nearly 6% during the forecast period.
FDA Grants Priority Review to Genentech’s Risdiplam for Spinal Muscular Atrophy
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and granted Priority Review …
ProtoKinetix AAGP® Dry Eye Therapy Program Launched
MARIETTA, Ohio–(BUSINESS WIRE)– #AAGP–ProtoKinetix AAGP® Dry Eye Therapy Program Launched
Glaukos Completes Acquisition of Avedro, Inc.
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …
EnChroma Makes New Indoor Color Blind Glasses Available to the Public
BERKELEY, Calif.–(BUSINESS WIRE)– #colorishere–New EnChroma® Cx1 Indoor DT glasses offer an improved indoor lens designed specifically for Deutan-type color blindness
Horizon Therapeutics plc Launches New Online Community Connecting People Living with Thyroid Eye Disease and Urging them to “Listen to Your Eyes”
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics today announced the launch of a new online community for people living with thyroid eye disease called “Listen to Your Eyes.”
Aerie Pharmaceuticals Receives European Commission Approval for Rhokiinsa® (netarsudil ophthalmic solution) 0.02%
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Outlook on the Global Contact Lens Market (2019-2023): Focus on Cosmetic Lens Markets – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Contact Lens Market With Focus on Cosmetic Lens Market: Size, Trends & Forecasts (2019-2023)” report has been added to ResearchAndMarkets.com’s offering. The global contact lens market has witnessed continuous g…
Glaukos Announces Participation in Piper Jaffray Healthcare Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …